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Cellular dNTP levels serve as a biomarker for the replicative
capacity of mammalian cells (for review, see Ref. 1). Consistent
with this function, numerous studies have reported that dNTP
contents in cancer cells and transformed cell lines are elevated
3–10-fold compared with normal cells and that dividing cells
have higher dNTP contents than non-dividing cells (1– 6). Cellular dNTP levels also fluctuate during the cell cycle and upon
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els are altered (6 –10). In addition, many viruses utilize cellular
dNTPs to carry out their replicative cycle. These viruses include lentiviruses, such as the human and simian immunodeficiency viruses (HIV-11 and SIV), which are unique among
retroviruses in their ability to infect both non-dividing cells,
such as terminally differentiated macrophages (11), and dividing cells, such as activated CD4⫹ T cells. Changes in cell
tropism between macrophages and T cells that occur during the
course of lentiviral infection are closely related to immunological and clinical manifestations of lentivirus infection (i.e.
CD4⫹ T cell decrease and AIDS). In contrast to lentiviruses,
oncoretroviruses productively replicate only in dividing cells
(11, 12). Therefore, it is intriguing to consider how lentiviral
DNA polymerases may have evolved to replicate efficiently in
quiescent cells (i.e. terminally differentiated/non-dividing
macrophages) that presumably contain low levels of dNTPs.
In this study, we established a sensitive dNTP assay to
measure dNTP concentrations in primary HIV-1-susceptible
host cells. Biochemical analysis revealed that HIV-1 reverse
transcriptase (RT) efficiently performs processive DNA synthesis under reaction conditions that contained dNTP concentrations equivalent to those found in macrophages. In contrast,
oncoretroviral RTs were unable to efficiently polymerize under
these conditions. Finally, we designed pseudotyped HIV-1 virus vectors that contained either wild-type RT or RTs with
mutations that affected dNTP binding affinity. An analysis of
reporter gene expression in vector-infected target cells revealed
that the mutant constructs could transduce only actively dividing cells (cell lines, primary activated T cells), whereas the
wild-type vectors could transduce both dividing and non-dividing (macrophage) host cells. Collectively, these data provide
evidence that the unique ability of HIV-1 to infect non-dividing
cells depends, at least in part, on the evolutionary adaptation of
its reverse transcriptase to function under conditions of limiting dNTP availability.
EXPERIMENTAL PROCEDURES

Materials
Oligonucleotides were purchased from Integrated DNA Technologies. Hexahistidine-tagged p66/p66 RT homodimers derived from HIV-1
(HXB2) (13, 14) and SIV (SIVMNECL8) (15) or RT monomers of murine
leukemia virus (MuLV) (16) were isolated from bacterial overexpression
systems described in our previous studies. Avian myeloblastosis virus

1
The abbreviations used are: HIV-1, human immunodeficiency virus
type 1; SIV, simian immunodeficiency virus; T/P, template-primer complex; RT, reverse transcriptase; MuLV, murine leukemia virus; AMV,
avian myeloblastosis virus; KF, Klenow fragment; GM-CSF, granulocyte-macrophage colony-stimulating factor; GFP, green fluorescent protein; MOI, multiplicity of infection.
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Retroviruses utilize cellular dNTPs to perform proviral
DNA synthesis in infected host cells. Unlike oncoretroviruses, which replicate in dividing cells, lentiviruses, such
as human immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency virus, are capable of efficiently
replicating in non-dividing cells (terminally differentiated macrophages) as well as dividing cells (i.e. activated
CD4ⴙ T cells). In general, non-dividing cells are likely to
have low cellular dNTP content compared with dividing
cells. Here, by employing a novel assay for cellular dNTP
content, we determined the dNTP concentrations in two
HIV-1 target cells, macrophages and activated CD4ⴙ T
cells. We found that human macrophages contained 130 –
250-fold lower dNTP concentrations than activated human CD4ⴙ T cells. Biochemical analysis revealed that,
unlike oncoretroviral reverse transcriptases (RTs), lentiviral RTs efficiently synthesize DNA even in the presence
of the low dNTP concentrations equivalent to those found
in macrophages. In keeping with this observation, HIV-1
vectors containing mutant HIV-1 RTs, which kinetically
mimic oncoretroviral RTs, failed to transduce human
macrophages despite retaining normal infectivity for activated CD4ⴙ T cells and other dividing cells. These results suggest that the ability of HIV-1 to infect macrophages, which is essential to establishing the early
pathogenesis of HIV-1 infection, depends, at least in part,
on enzymatic adaptation of HIV-1 RT to efficiently catalyze DNA synthesis in limited cellular dNTP substrate
environments.
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(AMV) RT and Klenow fragment (KF) were purchased from Stratagene
(La Jolla, CA) and New England Biolabs (Beverly, MA), respectively.

ent concentrations of RTs and dNTP for 10 min at 37 °C (see Fig. 1D
legend).

Steady-state Kinetic Analysis of dNTP Incorporation

Four different 19-mer DNA templates containing sequence variations (N) at the 5⬘ end nucleotide (5⬘-NTGGCGCCCGAACAGGGAC-3⬘)
were individually annealed to an 18-mer DNA primer (5⬘-GTCCCTGTTCGGGCGCCA-3⬘), which was 32P-labeled at its 5⬘ end (template:
primer, 4:1). The nucleotide at the 5⬘ end of the primer determines the
dNTP to be measured. The primer (160 pmol in 80 l) was labeled using
40 units of T4 polynucleotide kinase (New England Biolabs) with 80 Ci
of [␣-32P]ATP (Amersham Biosciences) for 30 min at 37 °C. An additional 40 units of T4 polynucleotide kinase was added for an additional
30-min period of labeling. After heat inactivation (95 °C, 10 min), the
labeled primer was split into four separate tubes annealed with each of
the four 19-mer templates (160 pmol) with the addition of 10⫻ STE
buffer (100 mM NaCl and 5 mM EDTA for final concentration) in a final
volume of 50 l. The template/primer mixture was incubated for 10 min
at 95 °C, 5 min at 55 °C, and 5 min at 22 °C and stored on ice until used.
The template/primer complexes (T/Ps) were extended using RT proteins in a standard dNTP assay reaction. Each assay reaction (20 l)
contained 0.2 pmol of T/P (10 nM, primer concentration), 2 l of appropriate dNTPs (Amersham Biosciences) or extracted cellular dNTPs, 25
mM Tris-HCl, pH 8.0, 100 mM KCl, 2 mM dithiothreitol, 5 mM MgCl2, 5
M (dT)20, and 0.1 mg/ml bovine serum albumin (New England Biolabs).
Reactions were initiated by adding excess RT proteins (60 nM) in relation to dNTP concentration (0.2– 6.4 nM or 4 –128 fmol in 20 l) and
incubated at 37 °C for 5 min. Reactions were terminated with 10 l of
40 mM EDTA, 99% formamide. Reaction products were immediately
denatured by incubating at 95 °C for 5 min, and 4 l of each 30 l of
final reaction mixture was quantitated by phosphorimaging analysis
(PerkinElmer Life Sciences) of 14% acrylamide-urea denaturing gels
(SequaGel, National Diagnostics; model S2 sequencing gel electrophoresis apparatus, Labrepco). Note that in our purification protocol,
⬃30 – 60% of the purified RT protein was active as determined by our
pre-steady-state kinetic assay using a similar 18-mer/40-mer primer/
RNA template (17, 18). The reaction with less RT (10 nM), which is still
a higher concentration than the highest dNTP concentration used (6.4
nM), gave a similar incorporation profile under the assay condition.

The steady-state kinetic assay protocol described by Boosalis et al.
(20) was modified to determine DNA polymerization efficiencies of DNA
polymerases with the 18-mer/19-mer template/primers used in the
dNTP assay (see above). Reaction conditions were the same as those
described in the dNTP assay except for DNA polymerase concentrations
(0.5–2 nM). For the analysis of dNTP incorporation kinetics, four different templates (5⬘ template nucleotides T, C, G, or A for dATP, dGTP,
dCTP, or dTTP incorporation, respectively) annealed to the 32P-labeled
18-mer primer were used (see above). The amounts of RTs and incubation times were adjusted to yield an extension that was 30 – 60% of the
total labeled primer (0.8 pmol) at the highest dNTP concentrations, and
the reactions were repeated with eight decreasing concentrations of
each dNTP. For HIV-1 RT, 5, 10, 20, 40, 80, 160, 320, and 720 nM dNTPs
were used, and for MuLV RT, 1, 2, 4, 8, 16, 32, 64, and 128 M were
used. We also measured the steady-state kinetic values using the processive reverse transcription with the 38-mer RNA annealed to the
32
P-labeled 17-mer. In this analysis, the different concentrations of all
four dNTP mixtures were used. Products (single nucleotide-incorporated primer or all extended products) were resolved in 14% polyacrylamide-urea gel and quantitated by phosphorimaging analysis using the
OptiQuant software (PerkinElmer Life Sciences). The kcat and Km values were determined from the Michaelis-Menten equation.

Standard Curves for Single Nucleotide Incorporation
The gels obtained from the incorporation assay (see Fig. 1A) were
subjected to phosphorimaging analysis (see above). The percent of
primer extension in each reaction was calculated by determining the
ratios of extended versus total (extended and unextended) primers.
Each signal for the extended products was normalized using the background signal in the control reactions incubated without RT (see Fig.
1C, lane C). The calculated percentage primer extension was plotted
from triplicate reactions as a function of the dNTP quantity used,
generating standard curves for all four dNTPs. The percentage primer
extension determined in triplicate reactions containing extracted cellular dNTPs was then extrapolated to the standard curves to determine
the dNTP contents present in the cellular samples.

Primer Extension by RT Proteins
The primer extension assay was modified from a previously described
misincorporation assay (18). Briefly, an RNA T/P was prepared by
annealing a 38-mer RNA (5⬘-AAGCUUGGCUGCAGAAUAUUGCUAGCGGGAAUUCGGCGCG-3⬘, Dharmacon Research) to the 17-mer
A primer (5⬘-CGCGCCGAATTCCCGCT-3⬘; template:primer, 2.5:1, Invitrogen) 32P-labeled at the 5⬘ end by T4 polynucleotide kinase. Assay
mixtures (20 l) contained 10 nM T/P, the RT protein concentrations
specified in the legends to Fig. 2, A and B, and 4 dNTPs at concentrations indicated in the figure legends under the condition described in
the dNTP assay above. Reactions were incubated at 37 °C for 5 min and
terminated for analysis as described in the dNTP assay. Concentrations
of RTs (i.e. 1 and 4⫻) and dNTPs (i.e. 4 and 0.04 M) used in each primer
extension experiment were described in each figure legend. This reaction condition allows multiple rounds of primer extension. We also
performed the single round primer extension. In this reaction, RTs were
preincubated with the 32P-labeled 17-mer/38-mer RNA template (10
nM), and the reaction was initiated by adding a mixture of dNTP (0.04
M) and a molar excess of cold T/P (1 M) for 3 min at 37 °C. For the trap
control, RTs were preincubated with a mixture of the 32P-labeled T/P
and the cold T/P, and the reaction was initiated by adding dNTP (0.04
M). We also employed a 120-nucleotide-long RNA template annealed to
a 32P-labeled 20-mer primer (19). This T/P was also extended by differ-

dNTP Extraction from Cells
The protocol for dNTP extraction from cells was similar to that
described previously (21). Briefly, cell pellets (5 ⫻ 104-2 ⫻ 106 cells)
were washed twice with 1⫻ Dulbecco’s phosphate-buffered saline (Mediatech) and resuspended in 100 l of ice-cold 60% methanol. Samples
were vortexed vigorously to lyse the cells and then heated at 95 °C for
3 min prior to centrifugation at 12,000 ⫻ g for 30 s. The supernatants
were collected and completely vacuum-dried using a SpeedVac (Savant)
with medium heat. The dried pellets were subsequently resuspended in
dNTP buffer (50 mM Tris-HCl, pH 8.0, and 10 mM MgCl2; 100 l for 1 ⫻
106 HeLa cells and 10 l for 1 ⫻ 106 primary cells), and usually 1–2 l
of the extracted dNTP samples were used for each 20-l single nucleotide incorporation reaction (see above). The proper dilutions of the
dNTP samples were prepared for the assay to make the primer extension values lie within the linear ranges of the dNTP incorporation
(2–32% primer extension). The extracted dNTP samples were stored at
⫺70 °C until used. Several different volumes of the extracted dNTP
samples were also used to confirm the linearity of the primer extension.
In addition, the dNTP samples were prepared from different cell numbers depending on the recovery efficiency of the primary cells from each
blood sample (see below). However, the dNTP content of each cell type
was normalized by pmol/1 ⫻ 106 (see Fig. 1F).

Isolation and Culture of Human T Cells and
Monocyte-derived Macrophages
Human macrophages and CD4⫹ T cells were isolated from human
buffy coats (Blood Research Institute) as described (22). Peripheral
blood mononuclear cells were harvested from Ficoll density gradients
(Lymphoprep, Axis-Shield PoC AS, Oslo, Norway), and monocytes were
then purified using immunomagnetic selection with anti-CD14 antibody-conjugated magnetic beads following the manufacturer’s recommendations (Miltenyi Biotech). CD4⫹ lymphocytes were isolated from
monocyte-depleted buffy coats by immunomagnetic selection using anti-CD4 antibody-conjugated magnetic beads. The purified human monocytes were incubated in 10-cm dishes in RPMI 1640 medium (Mediatech) containing 20% human AB serum (Sigma) for 4 days in the
presence of 5 ng/ml human recombinant GM-CSF (R&D Systems) and
then incubated for an additional 3 days in the absence of GM-CSF to
allow differentiation into macrophages. The purified resting T cells
were maintained in RPMI 1640 medium supplemented with 10% autologous human serum, although activated T cells were propagated in
RPMI 1640 medium supplemented with 10% autologous human serum
and 5 ng/ml phytohemagglutinin (Sigma) for 24 h and then incubated in
RPMI 1640 medium with 10% human serum and 5 ng/ml human
recombinant interleukin 2 (Sigma) for 3 days. These cell preparations
were to prepare for dNTP extracts and also for analysis of cell volumes
using confocal microscopy.

Pseudotyped Virus Cloning and Preparation
pHCMV-VSVG envelope vector (23) and pD3-GFP transfer vector,
which encodes the HIV-1 NL4-3 genome with the eGFP gene in place of
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Infection of Primary CD4⫹ T Cells and Monocyte-derived
Macrophage
T cells and macrophage were purified essentially as described above.
T Cell Infections—After 5 days of T cell stimulation with phytohemagglutinin and interleukin 2 (see above), 2 ⫻ 105 stimulated T cells
were infected in the presence of polybrene with a multiplicity of infection (MOI) of 100 based on HeLa cell titering. For QN virus infections,
an MOI of 65 was used because of trouble generating high titer QN
virus. These infections reflect the addition of viral stocks containing
200 –300 ng of p24. Infected cells were incubated at 37 °C and 5% CO2
in a 100-l total volume. Two hours post-infection, 100 l of RPMI 1640
medium with 10% heat-inactivated human AB serum and 4 ng/l
interleukin 2 was added, and infections were incubated for an additional 46 h. Cells were visualized and photographed by fluorescent
microscopy to detect GFP fluorescence by infected cells. The percent of
infection was determined after cells were prepared for flow analysis by
fixation with 0.5% formaldehyde.
Macrophage Infections—After the initial magnetic bead purification,
2 ⫻ 106 CD14⫹ cells/well were plated into 6-well plates and cultured in
RPMI 1640 medium with 2% heat-inactivated human AB serum and 5
ng/ml GM-CSF for 48 h. This was followed by a 48-h incubation in RPMI
1640 medium with 20% heat-inactivated human AB serum and 5 ng/ml
GM-CSF. Cells were then incubated for an additional 8 days in the
absence of GM-CSF, with fresh medium added after the initial 4 days.
Macrophages were infected with pseudotyped virus at an MOI of 40
based on HeLa cell titering and assuming 1 ⫻ 106 cells/well in the
presence of polybrene. These infections reflect the addition of viral
stocks containing 80 –130 ng of p24. Initial infections were in 250-l
volumes for the first 2 h at 37 °C and 5% CO2 followed by the addition
of 2 ml of RPMI 1640 medium with 20% heat-inactivated human AB
serum. Incubations were continued for up to 6 days, and cells were
periodically examined for GFP fluorescence by fluorescent microscopy.
Cells were fixed in 0.5% formaldehyde after disassociation from the
plates by 30 min of incubation with 2 mM EDTA and gentle scraping.
The percent of infection was determined by flow cytometry.
RESULTS AND DISCUSSION

Determination of dNTP Levels in HIV-1 Target Cells, Human
Macrophages, and Resting or Activated CD4⫹ T Cells—First,
we established a highly sensitive enzymatic dNTP assay that
2
Obtained through the AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, National Institutes of Health from Dr.
Richard Axel (24).

allowed us to measure the dNTP contents of primary and
non-dividing cells such as macrophages. For the enzymatic
measurement of each dNTP contained in a mixture of four
different dNTPs, we designed a 32P-labeled 18-mer primer that
could anneal to any of four different 19-mer DNA templates
(see “Experimental Procedures”). Because these dNTP assay
T/Ps contain only one of the four possible nucleotides at the 5⬘
protruding end of the template, DNA polymerases can incorporate only the complementary dNTP onto each of the four T/Ps.
Using the specific T/Ps, we found that HIV-1 RT efficiently
performed single nucleotide incorporation, even at very low
dNTP concentrations, compared with KF of Escherichia coli
DNA polymerase I (data not shown) and MuLV RT (see below).
When 200 fmol of T/Ps were extended by HIV-1 RT (60 nM) in
the presence of different amounts of the individual dNTPs for 5
min at 37 °C, 19-mer extended products were generated. As
shown in Fig. 1A, incorporation of dCTP and dTTP was detected at concentrations as low as 4 fmol, which extended ⬃2%
of the primers. Similar profiles were seen with dGTP and dATP
(data not shown). The percent of primer extension in each
reaction was then calculated to generate standard curves for
incorporation of each dNTP onto the appropriate template/
primer (Fig. 1B, dTTP and dGTP). No detectable primer extension was observed in control reactions lacking either HIV-1 RT
or the required dNTP Fig. 1C, lane C). The single nucleotide
primer extension reaction for each of the four dNTPs was found
to be linear for dNTP quantities between 4 and 128 fmol (0.2–
6.4 nM), as shown in the standard curve with dTTP and dGTP
(Fig. 1B) as well as with dATP and dCTP (data not shown). The
linear dNTP incorporation appeared to be affected at higher
dNTP amounts in some cases (see 128 fmol dTTP in Fig. 1B)
because the observed primer extension levels with 128 fmol of
dNTPs (55– 60%) were lower than expected (64% at 128 fmol).
Therefore, the upper dNTP limit of the assay should be 128
fmol. This suggested that the dNTP content measurement with
the dNTP samples extracted from cells should be performed
within the linear dNTP ranges (4 – 64 fmol of dNTP or 2–32% of
primer extension). The minimum detection of the dNTP content in this HIV-1 RT-based assay (4 fmol) is 25- and 500-fold
more sensitive than the KF (0.1 pmol) (21) and high pressure
liquid chromatography-based assays (⬎2 pmol) (25–28), respectively, that have been used previously for dNTP content
measurement.
These reactions contained excess HIV-1 RT in relation to
substrates, allowing depletion of provided dNTPs within the
linear range, as shown in Fig. 1. This explanation is evidenced
by the following: 1) the assay was performed at 10 and 20 min,
and no additional primer extension compared with the 5 min
standard reaction was observed (data not shown); and 2) the
assay showed a 1:1 correlation between the amount of extended
primer and the amount of dNTPs included in the reaction,
particularly at the low dNTP amount (e.g. adding 4 fmol of
dCTP resulted in 2% primer extension).
dNTP samples obtained from cells contained all four dNTPs
as well as structurally related rNTPs, which may be present in
cells with concentrations 200 –1000-fold higher than the dNTPs
(1). Thus, it is conceivable that an enzymatic dNTP assay
might be influenced by the presence of such a vast excess of
rNTPs. This is unlikely in the case of HIV-1 RT, which has been
shown to incorporate rNTPs very inefficiently (i.e. only when
their concentration is at least 0.5 mM) (29). Nonetheless, we
tested our assay by adding rNTPs at a concentration 10,000fold higher than the highest dNTP concentration in the linear
range of the assay, and rNTP incorporation was not detected
(Fig. 1C). A second potential concern with using a primer
extension reaction based on the HIV-1 RT is that this enzyme
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HIV-1 envelope, were used for preparing pseudotyped HIV-1. The
V148I and Q151N mutations were cloned into pD3-GFP (pNL4-3-based)
vector using the overlapping PCR with proper primers that were designed based on the pNL4-3 RT sequence. The created mutations were
confirmed by sequencing with the 3305 primer (5⬘-GCACTATAGGCTGTACTGTCC-3⬘), and correct SwaI relegation was confirmed with D3GFP SEQ SwaI F (5⬘-CAGGCCATATCACCTAG-3⬘) and D3-GFP SEQ
SwaI R (5⬘-TCTAACTGGTACCATAAC-3⬘) primers. 293FT cells (Invitrogen) were grown to ⬃90% confluency with Dulbecco’s modified
Eagle’s medium, 10% fetal bovine serum, and 500 g/ml G418 sulfate in
T-175 flasks. The cells were transfected with 5 g of envelope vector
and 25 g of transfer vector using Lipofectamine 2000 (Invitrogen)
following the manufacturer’s recommendations (in the absence of geneticin). Cells were split in half into two new T-175 flasks 16 h posttransfection. Supernatant was collected 48 and 72 h post-transfection
and stored at 4 °C. Virus was harvested by ultracentrifugation at
22,000 rpm for 2 h at 4 °C with the Beckman SW 28 rotor. Virus was
titrated by infection of HeLa cells2 in the presence of polybrene, and the
infection was monitored by fixation and flow cytometry analysis for
GFP expression 48 h post-infection. p24 levels were also measured
using the HIV-1 p24 antigen enzyme-linked immunosorbent assay test
system (Beckman).
As a control, transfections were also performed in the absence of the
pHCMV-VSVG vector, and this virus was titered on HeLa cells revealing no detectable GFP expression. In addition, controls were performed
by pretreating HeLa cells for 2 h prior to and during infection with 0.5
mM cycloheximide, which is a general translation inhibitor. Cells were
fixed and analyzed by flow cytometry 48 h post-infection. Results
showed that very little protein was carried over with the pseudotyped
virus preparations, as evidenced by ⬍1% GFP-positive cells with plus
cycloheximide infections compared with ⬎20% GFP-positive cells in
minus cycloheximide infections (data not shown).
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is known to be error-prone (i.e. capable of incorporating “incorrect” dNTPs) (30, 31). We therefore tested whether incorrect
dNTPs could be incorporated under the assay conditions used.
For this test, the dGTP-specific template/primer pair was extended in the presence of a mixture of dATP, dCTP, and dTTP
(0.5 M each), the three incorrect dNTPs; this incorrect dNTP
concentration is ⬃100-fold higher than the highest correct
dNTP concentrations that showed linear incorporation under
these assay conditions (6.4 nM dGTP). As shown in Fig. 1C, no
incorporation of incorrect dNTPs was observed even at this
artificially high concentration of incorrect dNTPs. In fact,
HIV-1 RT needs ⬃200 M incorrect dNTPs to carry out misincorporation under similar reaction conditions (32, 33). Therefore, incorrect dNTPs and rNTPs present in cellular dNTP

samples should not interfere with the determination of individual dNTP levels under the assay conditions established.
We used the HIV-1 RT-based assay to examine dNTP levels
in the major primary target cells for HIV-1 (i.e. human monocyte-derived macrophages and activated or resting CD4⫹ T
cells). For this analysis, dNTPs were extracted from these
primary cells (see “Experimental Procedures”), and the extracted dNTP samples with the proper dilutions were used as
the dNTP source in single nucleotide extension assays with
each of the four T/Ps. As shown in Fig. 1, D and F, human
macrophages were found to contain ⬃4- and ⬃20-fold less
dNTPs than resting and activated T cells, respectively. The
dNTP content of T cells determined in this assay was found to
be similar to that previously determined by the KF based assay
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FIG. 1. Primary cell dNTP content determination by the HIV-1 RT-based dNTP assay. A, dCTP and dTTP incorporation by HIV-1 RT
(60 nM) was measured using the dCTP-specific template/primer pair (200 fmol) in the presence of different amounts of dCTP. B, standard curve
for the incorporation of dTTP and dGTP onto the dTTP- and dGTP-specific template/primer pairs. The percent of primer extension in each reaction
was plotted after background normalization (see “Experimental Procedures”). Each data point was calculated from three independent reactions;
error bars denote the standard deviation from the mean. C, incorporation of incorrect dNTPs and rNTPs. The G-specific template/primer pair was
incubated with HIV-1 RT (60 nM) and 50 M rNTP or a mixture of three incorrect dNTPs (⫺dGTP), which corresponds to a mixture that contained
0.5 M each dTTP, dCTP, and dATP. D, dNTP samples were isolated from human activated (A/T) or resting (R/T) CD4⫹ T cells or CD14⫹
macrophages (M). dNTP samples contained in 1 (T cells) to 2 (macrophages) ⫻ 105 cells were used for each assay reaction using dGTP- or
dTTP-specific template/primer pairs. E, effect of other chemicals contained in the extracted dNTP samples. The dNTP assay was performed with
either pure dNTP or mixtures of pure and extracted dNTPs. The amounts of the pure dNTPs used in the reactions are shown below the gels, and
1 (T cells) or 2 (macrophages) l of the cellular dNTP sample was used. The percent of primer extension in each reaction is also shown. Two different
amounts of the T cell dNTP sample, 1 and 2⫻, were used. The results for all template/primer pairs with the extracted dNTP samples are
summarized in F. dNTP values shown represent mean values calculated from three independent experiments performed in triplicate; standard
deviations are shown for each value. All reactions were performed as described under “Experimental Procedures,” and products were analyzed by
electrophoresis through 14% denaturing polyacrylamide gels followed by phosphorimaging analysis (see “Experimental Procedures”).

RT and dNTP Content for Cell Type Specificity of HIV-1
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FIG. 2. Comparison of reverse transcription capability of lentiviral and
oncoretroviral RTs at different dNTP
concentrations. A 32P-labeled 17-mer
primer (S) was annealed to a 38-mer RNA
template and then extended by two lentiviral RTs (A), HIV-1 and SIV RTs, and
two oncoretroviral RTs (B), MuLV and
AMV RTs, in reactions containing each
dNTP at 4 M. Two different input levels
of RT activity were used in these reactions (1⫻ and 4⫻, as indicated). The RT
reactions were repeated with these same
two reverse transcription activities (4⫻
and 1⫻) in reactions that contained each
dNTP 0.04 M; the fully extended primer
is 38 nucleotides long (lane F). 4⫻ concentrations of RTs are as follows: HIV-1 RT,
3.2 nM; SIV RT, 6 nM; MuLV RT, 0.5 nM;
AMV RT, 2.25 nM. The same T/P used in A
and B was extended by HIV-1 (3.2 nM)
and MuLV RTs (0.5 nM) under the condition allowing a single round of primer extension at 0.04 M dNTP (C). A 32P-labeled 20-mer primer (S) annealed to a
120-nt-long RNA template encoding
HIV-1 RT genome (D) was extended at 4
and 0.04 M dNTP by the four RTs under
the same condition used in A and B. The
2⫻ concentration was used for the two
lentiviral RTs (H, 6.4 nM HIV-1 RT; S, 12
nM SIV RT), whereas the 8⫻ concentration was used for the two oncoretroviral
RTs (M, 4 nM MuLV RT; A, 9 nM AMV
RT). E, dNTP concentration-dependent
single nucleotide incorporation by MuLV
and HIV-1 RTs was determined on the
18-mer/19-mer assay T/Ps. The single nucleotide incorporation activity of these
two DNA polymerases at different dNTP
concentrations was analyzed using the Tspecific template/primer pair (10 nM) in
the presence of decreasing dTTP concentrations (50, 5, 0.5, and 0.05 M). The
18-mer and 19-mer primers indicate unextended and extended primers, respectively. Polymerase concentrations showing ⬃60% primer extension on this
template/primer pair at 50 M dTTP are 1
nM MuLV RT and 0.8 nM HIV-1 RT. F,
steady-state kinetic analysis of the two
DNA polymerases with the four 18-mer/
19-mer T/Ps is shown (see “Experimental
Procedures”). Results are from experiments performed in triplicate with standard deviations.
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FIG. 3. dNTP dependence of HIV-1
Wild-type (A), V148I (B), and Q151N
(C) RT mutants during multiple
round polymerization. The 32P-labeled
17-mer primer annealed to the 38-mer
RNA template was extended by equivalent activities of the three RTs (as determined by analysis of enzymatic activity
under reaction conditions that contained
5 M each dNTP). Reactions were then
conducted with decreasing equimolar concentrations of all four dNTPs and were
analyzed on a 14% denaturing polyacrylamide gel. Lanes 1– 8 correspond to 5, 2.5,
1, 0.5, 0.25, 0.1, 0.05, and 0.025 M concentrations of all four dNTPs, respectively. Reactions performed at concentrations that represent those found in
activated (A/T) and resting (R/T) T cells
and macrophages (M) are marked.

result supports the notion that the incorporation of the pure
dGTP was not significantly affected by the addition of the
extracted sample (2 l). Similar cases can be observed with the
2⫻ T cell samples as well as with the macrophage samples,
when the data shown in Fig. 1F (with only extracted dNTP
sample) and Fig. 1E (with mixtures of pure and extracted
dNTPs) are compared. We also performed the poly(rA)/oligo(dT)-based RT assay measuring the [3H]TTP incorporation in
the presence or absence of 2 l of cellular dNTPs samples, and
in this experiment also we did not observe any reduction of the
[3H]TTP incorporation by the cellular dNTP samples (macrophages, T cells, and HeLa cells; data not shown). Therefore, the
data shown in Fig. 1E, together with the observations from the
[3H]TTP incorporation RT assay, clearly demonstrate that
HIV-1 RT activity is either not affected or is only slightly
affected by the inhibitory effects of other chemicals contained
in the extracted dNTP samples. In fact, the protocol employed
in this assay has been established previously for similar types
of enzymatic dNTP assays (21). We also used several different
volumes of the extracted dNTP samples for the dNTP measurements, and with these varied amounts of the samples, we
observed the expected linear changes in the percent of primer
extension. These data allow us to use 1) the percentages of the
primer extension with the extracted cellular dNTP samples
and 2) the dNTP standard curves shown in Fig. 1B for determining the dNTP content in each extracted sample.
Because there is no compartmentalization of cellular dNTPs
between the nucleus and cytoplasm (1), the average cell volumes
have been used to calculate the cellular dNTP concentrations.
The dNTP concentrations in these three human primary cells
were then calculated by taking into account the volumes of these
cell types. The cell volumes of human macrophages and resting
and activated CD4⫹ T cells were calculated using confocal microscopy and found to be 2660, 186, and 320 m3, respectively,
which are similar to previously published estimates (34 –36).
Therefore, the calculated dNTP concentrations in human macrophages are ⬃130 –250-fold lower (⬃0.026 M) than in resting and
activated CD4⫹ T cells (3.4 and 6.2 M, respectively; Fig. 1D).
Reverse Transcription Activity of Retroviral RTs at dNTP
Concentrations Found in T Cells and Macrophages—Lentiviruses differ from oncoretroviruses in their ability to infect
non-dividing cells such as macrophages (11, 12). HIV-1 infection of terminally differentiated, tissue-resident cells of monocytic lineage may be especially important during viral trans-
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(21). We also confirmed the dNTP content of human resting
CD4⫹ T cells using the KF-based assay previously established,
but this assay required 10 –20-fold more cells per assay because
of the higher assay sensitivity limit (0.1 pmol).
Next, we tested the nonspecific inhibition of the HIV-1 RT
activity by other chemicals co-extracted with cellular dNTPs
under the dNTP assay condition. For this test, we performed
the dNTP assay with either pure dNTP (64 or 8 fmol of dTTP
for the macrophage samples and 16 fmol of dGTP for the T cell
samples; Fig. 1E) or mixtures of pure dNTP and the extracted
dNTP samples used in Fig. 1D. As shown in Fig. 1E, even with
2 l of the macrophage extract sample, which contains 16.8
fmol of dTTP (Fig. 1F), the primer extension with 64 fmol of
dTTP was not reduced. Rather, compared with the reaction
with only pure dTTP (30.1%), a slight increase (⬃7%) was
observed in the reaction with this mixture. This increase likely
resulted from the additional incorporation of dTTP contained
in the macrophages sample (16.8 fmol), which should have
given ⬃8% primer extension. More obviously, as shown in Fig.
1E, the reaction with the mixture of 8 fmol of pure TTP (theoretically giving 4% primer extension) and 2 l of the macrophage sample (16.8 fmol of TTP giving 8.4% primer extension)
showed 12.4% primer extension, whereas the reaction with
only 8 fmol of pure dTTP showed the expected 4.3% primer
extension. The 8.1% primer extension increase in the reaction
with this mixture likely resulted from the incorporation of the
16.8 fmol of dTTP (Fig. 1F) contained in the 2 l of the macrophage sample. As shown in Fig. 1E, the additive primer extension was also observed in the reactions with the mixtures of
pure dGTP (16 fmol, 7.6% primer extension) and the resting T
cell samples containing 28 (1⫻ and 1 l) or 56 (2⫻ and 2 l)
fmol of dGTP (giving additional 14.2 and 27.4% primer extensions, respectively) as well as activated T cells (data not
shown). In addition, the expected primer extension increases
were seen when the pure dNTPs (Fig. 1E) were added into the
reactions with only extracted samples (Fig. 1, D and F). For
example, the reaction with a mixture of 16 fmol of pure dGTP,
which gave 7.6% primer extension, and the resting T cell sample (1⫻ and 1 l) containing 28 fmol dGTP (theoretically giving
14% primer extension (Fig. 1F) or actually giving 13.1% primer
extension (Fig. 1D)) showed 21.8% primer extension (Fig. 1E).
This indicates that the 16 fmol of pure dGTP, which produces
8% primer extension, contributed to 7.8 (theoretical) to 8.7%
(actual calculated) primer extension increases. Therefore, this
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mission and early replication events (37, 38). In contrast, like
other RNA tumor viruses, MuLV (11) and AMV (39, 40) infection requires cell proliferation. However, AMV infection of
chicken embryo-derived macrophages has been described only
when these cells were actively dividing as confirmed by
[H3]thymidine incorporation and mitotic index (39, 40). Because the calculated dNTP concentration present in primary
macrophages is very low (⬃0.03 M), we performed a series of
experiments employing various substrates and reaction condi-
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FIG. 4. Transduction of primary human cells by pseudotyped lentivirus
vectors containing wild-type, V148I,
or Q151N RTs. Primary human cells
were infected with eGFP-encoding lentivirus vectors containing the indicated RT
variants (Wild-type, V148I, Q151N). T
cells were fixed 48 h post-infection with
0.5% formaldehyde, and macrophages
were fixed 120 h post-infection in 0.5%
formaldehyde after treatment with 2 mM
EDTA and gentle scraping. Flow cytometric analysis of eGFP expression in transduced CD4⫹ T cells (A) and macrophages
(B) from one representative experiment
are shown. The negative control (mock)
infections are shown in black, whereas
results from vector-transduced cells are
depicted by the green histograms. Total
cells were gated on the basis of physical
parameters (forward and side scatter),
and the percent GFP-positive cells was
determined after gating parameters were
set such that the percent GFP-positive
cells in the negative control cells was 1%.
C, representative images of macrophages
120 h post-infection are shown. Fluorescent images are shown (upper panels)
with corresponding bright field images
(lower panels); images were taken at ⫻14
magnification. A summary of flow cytometric results from one experiment performed in triplicate is shown in D.

tions to examine whether lentiviral (HIV-1 and SIV) and oncoretroviral (MuLV and AMV) RTs were able to execute processive DNA synthesis under reaction conditions that
contained dNTP concentrations present in macrophages (0.04
M) or T cells (4 M) (Fig. 2).
First, a 17-mer primer annealed to a 38-mer RNA template
was employed for monitoring reverse transcription. The RT
enzymes being compared were then added at two different
quantities (4 and 1⫻); as expected, these different levels of

51552

RT and dNTP Content for Cell Type Specificity of HIV-1
at lower dNTP concentrations, HIV-1 RT was able to polymerize
single nucleotide incorporation much more efficiently than
MuLV RT. Next, the steady-state kinetic parameters Km and kcat
were calculated under similar reaction conditions but with lower
RT activity than was used in Fig. 2E. As seen in Fig. 2F, the kcat
values for the two enzymes with the four dNTPs did not vary
greatly, whereas there was a large increase in the Km values for
the MuLV RT as compared with HIV-1 RT. Furthermore, in
processive DNA synthesis assays similar to Fig. 2, A and B, we
also found that the Km values of MuLV and AMV RTs were 23and 20-fold higher than that of HIV-1 RT, respectively, with
similar kcat values between these RTs (data not shown). Therefore, these Km differences confirm that at lower dNTP concentrations, HIV-1 RT is able to polymerize DNA more efficiently than
MuLV RT.
The data obtained from the various assays shown in Fig. 2
clearly suggest that the lentiviral RTs have evolved to efficiently
catalyze DNA polymerization even at very low dNTP concentrations (such as those found in primary macrophages). In contrast,
the oncoretroviral RTs may have adapted to efficiently catalyze
DNA synthesis only at the much higher dNTP concentrations (i.e.
4 M) that are present in actively dividing cells.
HIV-1 Replication in Human Primary Target Cells with Different dNTP Concentrations—To further examine the relationship between cellular dNTP content and retroviral replication,
we took advantage of two mutated derivatives of the HIV-1 RT,
V148I and Q151N, that had recently been shown by pre-steadystate kinetic analysis to have severely reduced dNTP binding
affinity (kd, 25.6- and 234.2-fold respectively) compared with
wild-type HIV-1 RT, even though these mutants possess wildtype levels of catalysis (kpol) (14, 17). As seen in Fig. 3, we
examined the dNTP concentration dependence of processive
DNA polymerization by these mutant RTs as compared with
wild-type RT. Each of the RTs exhibited similar levels of activity in reactions that contained high dNTP concentrations (i.e. 5
M in Fig. 3), which is supported by their identical kpol values.
The wild-type HIV-1 RT was also able to efficiently polymerize
DNA even at the low dNTP concentrations found in macrophages (Fig. 3A). However, similar to the two oncoretroviral
RTs tested above (Fig. 2B), the two mutant HIV-1 RTs were
significantly diminished in their ability to conduct processive
DNA synthesis at the low dNTP concentrations found in macrophages. The dNTP binding to the active site of the mutant RTs
likely becomes a rate-limiting step during the steady-state
primer extension reaction at low dNTP concentrations. Overall
DNA polymerization capability at the dNTP concentrations
found in macrophages is greatest for wild-type RT, followed by
V148I RT and then Q151N RT, which displayed the most
significant decrease in dNTP binding affinity (14, 17). Our
kinetic analysis demonstrated that, like these HIV-1 dNTP
binding mutants, MuLV RT also has a 40 –75-fold higher kd
than wild-type HIV-1 (data not shown). Basically, these HIV-1
RT dNTP-binding mutants kinetically mimic MuLV (Fig. 2B).
Next, to examine the effect of RT dNTP binding affinity on
lentiviral replication in primary cells, we generated pseudotyped
HIV-1 vectors that contained an eGFP reporter cassette and that
were isogenic except for the previously defined RT mutations (i.e.
wild type, V148I, and Q151N). The pseudotyped particles were
titered on HeLa cells, and then equivalent MOIs were used to
infect primary human T cells and macrophages. As seen in Fig. 4,
A and D, all three vectors had similar abilities to transduce
activated human T cells and transformed cell lines (i.e. HeLa
cells) containing high cellular dNTP concentrations, which is
consistent with the efficient polymerization capability of wildtype RTs and these mutant HIV-1 RTs at high concentrations
(Fig. 2C) and their similar kcat values (Fig. 2D). In contrast, the
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input enzyme resulted in an ⬃4-fold difference in the amount of
fully extended primer (Fig. 2, A and B, lane F) at the dNTP
concentration present in T cells (4 M). However, when the
primer extension was performed in the presence of 0.04 M of
each dNTP (i.e. the concentration present in macrophages), the
two lentiviral RTs still maintained efficient DNA synthesis
capabilities (Fig. 2A), whereas the two oncoretroviral RTs
showed a dramatic reduction in their ability to conduct multiple rounds of DNA synthesis (Fig. 2B). Note that slightly more
reverse transcription activity was added for reactions with
MuLV RT to demonstrate that even with more DNA polymerase activity, MuLV RT did not extend the primer efficiently at
0.04 M dNTP. In addition, reactions were performed with
HIV-1 and MuLV RTs for longer incubation times with 0.04 M
dNTPs, and we observed further extension of the primer, implying that all substrate dNTPs were not depleted under these
reaction conditions (data not shown). Therefore, the low levels
of primer extension seen for MuLV RT at 0.04 M dNTP concentrations are not because of dNTP depletion.
Second, we examined the effect of dNTP concentration on the
DNA polymerization of HIV-1 and MuLV RTs under the condition allowing a single round of primer extension. This analysis
employed the same reaction condition as described in the legend
for Fig. 2, A and B (multiple round primer extension), except
using a trap that is a 100-fold molar excess of cold T/P. In this
reaction, HIV-1 and MuLV RTs (4⫻ concentration) were preincubated with the 32P-labeled 17-mer primer annealed to the
38-mer RNA template, and then the RT reaction was initiated by
adding a mixture of 0.04 M dNTP and the cold T/P trap. As
shown in Fig. 2C, under this single round extension condition
with 0.04 M dNTP, less primer extension was observed in the
reaction with HIV-1 RT than with the multiple round primer
extension by HIV-1 RT at 0.04 M (Fig. 2A). We also confirmed
the single round primer extension by initiating the reaction containing RTs preincubated with both the cold trap and the 32Plabeled T/P by adding 0.04 M dNTPs. In this trap control, no
primer extension was observed (data not shown), indicating that
the data shown in Fig. 2C was generated under the single round
primer extension condition. Indeed, as shown in Fig. 2C, HIV-1
RT was still able to perform the single round of the primer
extension very efficiently at 0.04 M dNTP compared with MuLV
RT, which did not incorporate more than one nucleotide. This
confirms the dNTP utilization discrepancy between HIV-1 RT
and MuLV RT at low dNTP concentrations.
Third, we also used the multiple round primer extension
assay using a 120-nucleotide-long HIV-1 RNA template annealed to a 32P-labeled 20-mer primer (19). As shown in Fig.
2D, even with a 4-fold greater RT activity (8⫻; see 4 M dNTP
reactions), the two oncoretroviral RTs (M, MuLV RT; A, AMV
RT) showed significant low primer extension at 0.04 M dNTP,
compared with the two lentiviral RTs (H, HIV-1 RT; S, SIV
RT). This result is similar to those described in Fig. 1, B and C,
using the 38-mer RNA template.
Last, we examined the effect of the dNTP concentration on the
DNA synthesis kinetics of HIV-1 and MuLV RTs, comparing the
steady-state kinetic parameters of these two RTs measured by a
single nucleotide incorporation assay. This experiment was performed on the 18-mer/19-mer template/primer used for the dNTP
assay but with more limiting RT concentrations than those used
in Fig. 1A. Fig. 2E demonstrates the qualitative difference between HIV-1 and MuLV RT in the single nucleotide incorporation with varying dNTP concentrations. Initially, RT activity
showing ⬃60% extension at 50 M dTTP under the standard
reaction condition described in Fig. 2A was determined, and then
the same reactions were repeated at three different lower dTTP
concentrations (5, 0.5, and 0.05 M). Indeed, as shown in Fig. 2E,
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vectors containing the V148I and Q151N RT mutants were
greatly diminished in their ability to transduce primary macrophages even with higher MOI infections (Fig. 4, B–D). Therefore,
this reflects the enzymatic inability of these mutant RTs to synthesize DNA at low dNTP concentrations and suggests that the
dNTP binding affinity of lentiviral RTs is a key contributor to
viral replication in macrophages.
In summary, using both biochemical and virological analyses, we were able to investigate the relationship between cellular dNTP pools, RT binding affinity for dNTPs, and viral
replication in non-dividing host primary cells that contain limiting dNTP concentrations. Our results strongly suggest that
the enzymatic adaptation of the HIV-1 RT DNA polymerase
active site to catalyze DNA synthesis in cellular environments
that contain low levels of dNTPs is a major contributor to the
unique ability of these viruses to efficiently replicate in macrophages. Therefore, this study provides evidence that RT plays
an essential role in establishing and maintaining the macrophage tropism of HIV-1 during the course of viral infection,
which presents unique virological and pathological characteristics that differentiate lentiviruses from oncoretroviruses.
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